Cargando…

Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn’s Disease Exacerbations

BACKGROUND AND AIMS: Crohn’s disease [CD] is a chronic inflammatory disorder of the gastrointestinal tract characterised by alternating periods of exacerbation and remission. We hypothesised that changes in the gut microbiome are associated with CD exacerbations, and therefore aimed to correlate mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klaassen, Marjolein A Y, Imhann, Floris, Collij, Valerie, Fu, Jingyuan, Wijmenga, Cisca, Zhernakova, Alexandra, Dijkstra, Gerard, Festen, Eleonora A M, Gacesa, Ranko, Vich Vila, Arnau, Weersma, Rinse K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142399/ https://www.ncbi.nlm.nih.gov/pubmed/31066440 http://dx.doi.org/10.1093/ecco-jcc/jjz077

Ejemplares similares

SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects
por: Collij, Valerie, et al.
Publicado: (2019)

Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome
por: Bolte, Laura A, et al.
Publicado: (2021)

Patient attitudes towards faecal sampling for gut microbiome studies and clinical care reveal positive engagement and room for improvement
por: Bolte, Laura A., et al.
Publicado: (2021)

Whole exome sequencing analyses reveal gene–microbiota interactions in the context of IBD
por: Hu, Shixian, et al.
Publicado: (2021)

Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications
por: Collij, Valerie, et al.
Publicado: (2020)

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota
por: Vich Vila, Arnau, et al.
Publicado: (2020)

The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease
por: Ruigrok, Renate A A A, et al.
Publicado: (2021)

Analysis of 1135 gut metagenomes identifies sex-specific resistome profiles
por: Sinha, Trishla, et al.
Publicado: (2018)

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease
por: Gacesa, R., et al.
Publicado: (2021)

Pharmacomicrobiomics: a novel route towards personalized medicine?
por: Doestzada, Marwah, et al.
Publicado: (2018)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Role of the gut microbiome in mediating lactose intolerance symptoms
por: Brandao Gois, M F, et al.
Publicado: (2022)

Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity
por: Chen, Lianmin, et al.
Publicado: (2020)

Riboflavin Supplementation in Patients with Crohn’s Disease [the RISE-UP study]
por: von Martels, Julius Z H, et al.
Publicado: (2020)

Impact of occupational pesticide exposure on the human gut microbiome
por: Gois, Milla F. Brandao, et al.
Publicado: (2023)

Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome
por: Chen, Lianmin, et al.
Publicado: (2022)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

Diversity and Ecology of Caudoviricetes Phages with Genome Terminal Repeats in Fecal Metagenomes from Four Dutch Cohorts
por: Gulyaeva, Anastasia, et al.
Publicado: (2022)

Multi-ethnic studies in complex traits
por: Fu, Jingyuan, et al.
Publicado: (2011)

The emerging role of the small intestinal microbiota in human health and disease
por: Ruigrok, Renate A. A. A., et al.
Publicado: (2023)

Habitual dietary intake of IBD patients differs from population controls: a case–control study
por: Peters, Vera, et al.
Publicado: (2020)

Interaction between drugs and the gut microbiome
por: Weersma, Rinse K, et al.
Publicado: (2020)

The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
por: Fu, Jingyuan, et al.
Publicado: (2015)

Health-related quality of life is linked to the gut microbiome in kidney transplant recipients
por: Swarte, J. Casper, et al.
Publicado: (2023)

Large-scale genetic analyses in an understudied disease: haemorrhoidal disease
por: Festen, Eleonora A M, et al.
Publicado: (2021)

Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease
por: Hu, Shixian, et al.
Publicado: (2021)

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

Expressing the Differences between Crohn Disease and Ulcerative Colitis
por: Wijmenga, Cisca
Publicado: (2005)

Correction to: The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Donor tobacco smoking is associated with postoperative thrombosis after primary liver transplantation
por: Li, Yanni, et al.
Publicado: (2020)

Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease
por: Alexdottir, Marta S., et al.
Publicado: (2022)

Studying the gut virome in the metagenomic era: challenges and perspectives
por: Garmaeva, Sanzhima, et al.
Publicado: (2019)

A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease
por: Festen, Eleonora A. M., et al.
Publicado: (2011)

Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics
por: Voskuil, Michiel Dirk, et al.
Publicado: (2019)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Understanding human gut diseases at single-cell resolution
por: Bigaeva, Emilia, et al.
Publicado: (2020)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease
por: Bourgonje, Arno R., et al.
Publicado: (2022)

The MHC locus and genetic susceptibility to autoimmune and infectious diseases
por: Matzaraki, Vasiliki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k04reda9frvp1jair1dat3r1p8